A Phase I, Multi-Center, Open-Label Study to Evaluate the Safety and Tolerability, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of KF-0210 in Patients with Advanced Solid Tumors
- Richardson, Gary (Primary Chief Investigator (PCI))
- Hoon, Lai Li (Project Manager)
Project: Research